MTOR and obesity due to melanocortin 4 receptor deficiency: In addition to genetic mutations, other significant contributors to the development and progression of PTDM include immunosuppressive agents (specifically calcineurin and mTOR inhibitors), viral infections, family history of diabetes, chronic corticosteroid use, deceased donor status, obesity, metabolic syndrome, and proteinuria [42,45–47].